Experimental Rnomics: Towards The

Identification And Characterization Of

Non-Protein-Coding Ribonucleic Acids In

Pathogenic Agent, Salmonella Typhi by Zakaria,  Robaiza
EXPERIMENTAL RNOMICS: TOWARDS THE 
IDENTIFICATION AND CHARACTERIZATION OF 
NON-PROTEIN-CODING RIBONUCLEIC ACIDS IN 
PATHOGENIC AGENT, SALMONELLA TYPHI 
ROBAIZA BIN ZAKARIA 
UNIVERSITI SAINS MALAYSIA 
2008 .. 
EXPERIMENTAL RNOMICS: TOWARDS THE IDENTIFICATION AND 
CHARACTERIZATION OF NON-PROTEIN-CODING RIBONUCLEIC ACIDS 
IN PATHOGENIC AGENT,SALMONELLA TYPHI 
by 
ROBAIZA BIN ZAKARIA 
Thesis submitted in fulrillment ofJbe requirements 
for the degree of 
Doctor of Philosophy 
June 2008 
To, 
My late father and mother, 
My family and 
Myfriends. 
DEDICATION 
11 
ACKNOWLEDGEMENTS 
In the name of Allah the most merciful and the most compasionate. All praise and 
gratitude is due to Allah and may peace and blessing be upon the prophet Muhammad 
(saw) and his family and his companion. 
First of all I would like to thank the Almighty God. I truly believed that without 
Him paving the road, I won't be able to meet all the "great hearts" and "helping hands" 
when ever I am in difficulties. 
I am most grateful to my supervisor Prof. M. Ravichandran and Associate Prof. 
Tang Thean Hock, who have supervised the whole of this thesis work, for their guidance, 
discussions and most of all for their support, understanding and patience. I will never 
forget how great their hearts are in helping me and giving me hope throughout the 
challenging period of hard time during this work. 
I would like to thank Prof. Asma Ismail as the Director of the Institute for 
Research in Molecular Medicine (INFORMM), who has gave the opportunity for me to 
pursue my PhD and to carry-out this study in INFORMM and for accepting me as the 
family member of INFORMM. . 
I would also like to express my gratitude· to Associate Prof. Mohd Radzi (Head 
Department of Microbiology and Parasitology) and Prof. Abdul Aziz Baba (Dean of 
PPSP) for their great support. My gratitude also goes to the IPS and Human Resource-
RLKA ofUSM for giving me the oppurtunity to pursue my PhD. 
I would like to express my deepest gratitud~_ to Dr Timofey S. Rozhdestvensky 
and Venkata Suresh Babu Chinni at the University of MUnster, Gennany who have 
encouraged, supported, argued, criticized and worked shoulder to shoulder as a team. 
I would like to thank all my friends in lNFORMM: and Department of 
Microbiology and Parasitology, and colleagues. Their presence had given me invaluable 
experiences and made life interesting inside and outside the lab. 
Last but not least, my deepest gratitude to my wife, Zanaidah and my childrens -
Abang Alif, Abang Afiq and Adik Akif for their unremitting support and patience. 
iii 
TABLE OF CONTENTS 
Page 
DEDICATION .................................................................................................................... .ii 
ACKN"OWLEDGEMENTS ............................................................................................... .iii 
TABLE OF CONTENTS ................................................................................................... .iv. 
LIST OF T ABLES ............................................................................................................... ix 
LIST OF FIGURES .............................................................................................................. x 
LIST OF ABBREVIATIONS ................................................................. ~ .......................... xii 
ABSTRAK TESIS ............................................................................................................. xiv 
THESIS ABSTRACT ....................................................................................................... xvi 
CHAPTER 1 - INTRODUCTION 
(1.1) General Introduction .................................................................................................. 1 
(1.2) Non-Protein-Coding RNAs (npcRNAs) ..................................................................... 5 
(1.3) Characteristic and Biogenesis ofnpcRNAs ............................................................ '" 7 
(1.4) Known Function ofnpcRNAs ................................................................................... 11 
(1.4.1) npcRNA Function in Post-transcriptional Gene Silencing ........................... 13 
(1.4.2) npcRNA Functions in RNA Editing .............................................................. 16 
(1.4.3) npcRNA Functions in Pre-mRNA Splicing .................................................. 16 
" .. -
(1.4.4) npcRNA Functions in Protein Stability ......................................................... 19 
(1.4.5) n~RNA Fuootions in Nucleotide Modification of RNA .............................. 19 
(1.4.6) npcRNA Functions ip mRNA Stability and Translation ............................... 21 
iv 
(1.4.7) npcRNA Functions in Growth Phases or Developmental Regulation .......... 26 
(1.4.8) npcRNA Functions in DNA Transcriptions .................................................. 26 
(1.4.9) npcRNA Functions in Chromosome Replication .......................................... 27 
(1.4.10) npcRNA Functions in RNA Processing ...................................................... 27 
(1.4.11) npcRNA Functions in Protein Synthesis ..................................................... 28 
(1.4.12) npcRNA Functions in Protein Translocation .............................................. 28 
(1.5) RNomics: Identification and Characterization ofnpcRNAs .................................... 28 
(1.5.1) Computational RNomics ............................................................................... 30 
(1.5.2) Experimental RNomics ................................................................................. 31 
(1.6) The Pathogenic Agent: Salmonella enterica serovar Typhi ..................................... 33 
(1.6.1) Salmonella Typhi Genome ............................................................................ 34 
(1.7) Research Objectives ................................................................................................. 36 
CHAPTER 2 - MATERIALS AND METHODS 
(2.1) Materials ............................................................ ~ . ." .................................................... 38 
(2.1.1) Chemicals and Enzyrnes ................................................................................ 38 
(2.1.2) Membranes .................................................................................................... 38 
(2.1.3) Kits and Other Materials ............................................................................... 38 
(2.1.4) Electrophoresis .............................................................................................. 39 
(2.1.5) Radio Isotopes ............................................................................................... 40 
(2.1.6) Bacteria Strains ............................................................................................. 40 
(2.1.6.1) Salmonella Typhi USM05 Isolate .......................................................... 40 
(2.1.6.2) Escherichia coli K12 Strain ................................................................... 40 
v 
(2.1.6.3) Escherichia coli TOPIO Competence Cells ........................................... 40 
(2.1.7) Oligonucleotides ............................................................................................ 41 
(2.1.7.1) Oligonucleotides Used for cDNA Synthesis ....................... ; .................. 41 
(2.1.7.2) Oligonucleotides Used for Amplification of the cDNA-Plasmid-DNA 41 
(2.1.7.3) Oligonucleotides Used for Northern Blot Hybridization ....................... 41 
(2.1.7.3.1) Oligonucleotides for S. Typhi ......................................................... 41 
(2.1. 7.3 .1.1) Oligonucleotides for npcRNAs in the Intergenic Regions ....... 41 
(2.1. 7.3 .1.2) Oligonucleotides for npcRNAs Antisense to ORFs ................. 42 
(2.1.7.3.1.3) Oligonucleotides for npcRNAs Overlapping the ORFs ........... 44 
(2.1.7.3.1.4) Oligonucleotides for npcRNAs Present at Multiple Locations 44 
(2.1.7.3.2) Oligonucleotides for E. coli KI2 ..................................................... 45 
(2.1.7.3.2.1) Oligonucleotides for npcRNAs in the Intergenic Regions ....... 45 
(2.1.7.3.2.2) Oligonucleotides for npcRNAs Antisense to ORFs ................. 45 
(2.1.7.3.2.3) Oligonucleotides for npcRNAs Overlapping the ORFs ........... 46 
(2.1. 7.3.2.4) Oligonucleotides for npcRNAs Present at Multiple Locations 46 
(2.2) Methods .................................................................................................................... 47 
(2.2.1) Preparation of Solutions and Chemicals ....................................................... 47 
(2.2.1.1) Preparation of DE PC-Treated Deionized Distilled Water .......... ; .......... 47 
(2.2.1.2) Preparation of Glassware and Plastic Container .................................... 48 
(2.2.2) Preparation of S. Typhi USM05 Cell ............................................................ 48 
(2.2.2.1) Determination of S. Typhi USM05 Standard Growth Curve ................. 48 
(2.2.2.2) Culturing and Harvesting of S. Typhi CeiL ........................................... 49 
(2.2.3) Nucleic Acids Extraction .............................................................................. 49 
vi 
(2.2.3.1) Extraction of Total Genomic RNA ........................................................ 49 
(2.2.3.2) Extraction of Genomic DNA .................................................................. 50 
(2.2.3.3) Phenol/Chloroform Extraction ............................................................... 51 
(2.2.3.4) Elution of Nucleic Acids from Gel Slices .............................................. 51 
(2.2.4) Construction of the cDNALibrary for npcRNAs .......................................... 52 
(2.2.4.1) Size Selection of Total RNA .................................................................. 52 
(2.2.4.2) Treatment of Size-selected RNA with Tobacco Acid Pyrophosphatase 
(TAP) ..................................................................................................... 52 
(2.2.4.3) C-tailing of Size-selected RNAs .................................. : ......................... 52 
(2.2.4.4) Ligation of Sal I Adapter to the 5' -end of C-tailed RNA ....................... 53 
(2.2.4.5) cDNA Synthesis ..................................................................................... 53 
(2.2.5) Sequence Analysis and Characterization of cDNA Clones .......................... 55 
(2.2.6) Polymerase Chain Reaction (PCR) ............................................................... 56 
(2.2.7) Purification of Plasmid DNAlPCR Products ................................................ 56 
(2.2.8) Northern Blot Analysis .................................................................................. 56 
(2.2.9) End-labeling of OligonucIeotides .................................................................. 57 
(2.2.10) DNA Sequencing ......................................................................................... 57 
(2.2.11) Sequence Analysis ....................................................................................... 58 
(2.2.12) Databases ..................................................................................................... 58 
CHAPTER 3 - RESULTS AND DISCUSSION 
(3.1) Detennination of Growth Phases for S. Typhi USM05 ........................................... 59 
(3.2) Research Strategy ..................................................................................................... 60 
Vll 
(3.3) Analysis of the cDNA Library Representing Novel npcRNA Candidates from S. 
Typhi USM05 .......................................................................... : ............................... 71 
(3.4) Sequences Homology of S. Typhi USM05 Novel npcRNA Candidates in S. Typhi 
Ty2andE. coliK12 .................................................................................................• 77 
(3.5) Expression Analysis of Potential Novel npcRNA Candidates of S. Typhi USM05 
and E. coli K12 by Northern Blot Hybridization ..................................................... 80 
(3.5.1) Expression of Novel npcRNA Candidates .................................................... 82 
(3.5.2) Expression Features of Novel npcRNA Candidates ..................................... 83 
(3.6) Classification of potential novel npcRNAs candidates in S. Typhi USM05 ............ 93 
(3.6.1) npcRNAs Transcribed from the Intergenic Region ....................................... 93 
(3.6.2) npcRNAs Transcribed in the Antisense Orientation of an ORF ................. 104 
(3.6.3) npcRNAs Overlapping ORF ....................................................................... 113 
(3.6.4) npcRNAs Located at Several Transcription Locations ............................... 123 
CHAPTER 4 - CONCLUSION AND FUTURE STUDY 
Conclusion and Future Study ........................................................ : .................................. 131 
REFERENCES ................................................................................................................ 134 
APPENDICES ................................................................................................................. 148 
PUBLICATIONS ............................................................................................................ 164 
Vlll 
LIST OF TABLES 
Page 
Table 3.1 OD6oo reading for S. Typhi USM05 culture ................................................. 61 
Table 3.2 Analysis of potential novel npcRNA candidates in S. Typhi USM05 and 
E. coli KI2 ................................................................................................... 84 
Table 3.3 Compilation of28 novel npcRNA candidates transcribed from intergenic 
region ........................................................................................................... 95 
Table 3.4 Compilation of 29 novel npcRNA candidates transcribed in the antisense 
orientation of an ORF ........................ ' ........................................................ 105 
Table 3.5 Compilation of 18 novel npcRNAs candidates overlapping ORF ............ 114 
Table 3.6 Compilation of seven novel npcRNAs candidates with sequence homology 
located at multiple locations ...................................................................... 124 
IX 
LIST OF FIGURES 
Page 
Figure 1.1 The proportion of non-protein-coding and protein-coding sequences in 
several model organisms ................................................................................ 3 
Figure 1.2 The organization ofnpcRNA genes ............................................................. l0 
Figure 1.3 Overview and model ofDsrAlHfq/1poS-mediated regulation ..................... 12 
Figure 1.4 Mechanisms of action for siRNA and miRNA ............................................ 15 
Figure 1.5 Mechanism ofU insertion/deletion RNA editing ........................................ 17 
Figure 1.6 Spliceosome assembly ................................................................................. 18 
Figure 1.7 Mechanism and function oftmRNA ............................................................ 20 
Figure 1.8 Structural features of CID box snoRNAs ..................................................... 22 
Figure 1.9 Structural features ofHJACA box snoRNAs ............................................... 23 
Figure 1.10 Mechanism of translational inhibition/activation inE. coli directed by 
npcRNAs ...................................................................................................... 24 
Figure 1.11 Schematic presentation of the systemic identification of novel npcRNAs 
candidates ........................................... ~·;~ ....................................................... 32 
Figure 3.1 Growth curve of S. Typhi USM05 ............................................................... 62 
Figure 3.2 Total RNA extracted from the lag, exponential and stationary phase of S. 
Typhi USM05 .............................................................................................. 63 
Figure 3.3 The treatment of size-selected total RNA with TAP ................................... 64 
Figure 3.4 Schematic presentation of a modified systemic identification of novel 
npcRNAs candidates ............................. ~ ......................................... , ............. 66 
Figure 3.5 The NotJlSalI digested amplicons separated on a 2% agarose gel.. ............. 68 
Figure,J.6 An initial screening of228 S. Typhi USM05 cDNA clones ........................ 70 
Figure 3.7 Sequences analysis of S. Typhi cDNA clones ............................................. 72 
x 
Figure 3.8 Final grouping and sequence homology of the npcRNA candidates ........... 75 
Figure 3.9 Polyacrylamide gel electrophoresis of S. Typhi USM05 and E. coli K12 total 
RNA from three different growth phases .................................................... 81 
Figure 3.10 The expression patterns of npcRNA candidates .......................................... 85 
Figure 3.11 Schematic overview of the expression features observed in 38 novel 
npcRNA candidates with NB result.. .......................................................... 87 
Figure 3.12 Genomic context and NB result for StyR-99, StyR-lll and StyR-280 ...... 97 
Figure 3.13 Genomic context and NB result for StyR-56, StyR-59, StyR-161, 
StyR-381, StyR-3, StyR-47, StyR-362 and StyR-333 ............................... 100 
Figure 3.14 Genomic context and NB result for StyR-122, StyR-137, StyR-196, 
StyR-252 and StyR-369 .................................................. : .......................... 107 
Figure 3.15 Genomic context and NB result for StyR-254, StyR-264 and 
StyR-263 .................................................................................................... 109 
Figure 3.16 Genomic context and NB result for StyR-151, StyR-199, StyR-234, 
StyR-248 and StyR-358 .................. ~ .......................................................... 112 
Figure 3.17 Genomic context and NB result for StyR-296, StyR-51, StyR-74, 
StyR-341, StyR-219 and StyR-250 ............................................................ 116 
Figure 3.18 Genomic context and NB result for StyR-29, StyR-328, StyR-50 and 
StyR-281 .................................................................................................... 120 
Figure 3.19 Genomic context and NB result for StyR-103, StyR-186, StyR-207, 
StyR-216, StyR-327 and StyR-329 ........................................................... 126 
Xl 
ATP 
BSA 
cDNA 
CTP 
ddH20 
DEPC 
DNA 
dNTP 
DTT 
EDTA 
ESTs 
fRNAs 
gRNA 
Hfq 
IGR 
IS 
LB 
M 
MDR 
miRNAs 
MnCh 
mRNA 
NaCI 
NaOAc 
NB 
NCBI 
ncRNAs 
nmRNAs 
npcRNAs 
OD260 
OD600 
OD260/280 
ORF 
PCR 
pre-mRNAs 
pre-rRNAs 
pre-tRNAs 
RE 
RIse 
RNA 
RNAi 
RNP 
LIST OF ABBREVIATIONS 
- adenosine triphosphate 
- bovine serum albumin 
- complementary DNA 
- cytosine triphosphate 
- de-ionized distilled water 
- diethyl pyrocarbonate 
- deoxyribonucleic acid 
- dideoxynucleotide triphosphate 
- dithiothreitol 
- ethylene diamine tetra acetic acid 
- expressed sequence tags 
- functional RNAs 
- guide-RNA 
- host factor 1 protein 
- intergenic region 
- insertion sequence 
- Lauria Bertani media 
- molar 
- multidrug resistance 
- micro RNAs' 
- Manganese chloride 
- messenger-RNA 
- Sodium chloride 
- Sodium acetate 
- Northern Blot 
- National Center for Biotechnology Information 
- non-coding RNAs 
- non-messenger RNAs 
- non-protein-coding RNAs 
- optical density at 260 nm wavelength 
- optical density at 600 nm wavelength 
- the ratio of optical density at 260 and 280 nm wavelength 
- open reading frame 
- polymerase chain reaction 
- precursors of messeng~r RNAs 
- precursors of ribosomal RNAs 
- precursors of transfer RNAs 
- restriction enzyme 
.. RNA",induced'silencing complex, 
- ribonucleic acid 
- RNA interference 
- ribonucleoprotein 
xu 
rRNA 
SDS 
SELEX 
siRNAs 
snRNAs 
snRNP 
snmRNAs 
sncRNAs 
snoRNA 
snoRNPs 
SR 
sRNAs 
SRP 
stRNAs 
TAP 
TAE 
TBE 
TEFB 
tRNA 
tmRNAs 
UTR 
utRNAs 
v/v 
w/v 
- ribosomal-RNA 
- sodium duodecyl sulfate 
- Systematic Evolution of Ligands by Exponential Enrichment 
- small interfering RNAs 
- small nuclear RNAs 
- small nuclear RNA-ribonucleoprotein complex 
- small non-messenger RNAs 
- small non-coding RNAs 
- small nucleolar RNA 
- small nucleolar RNA -ribonucleoprotein particles 
- signal recognition particle - membrane-associated receptor complex 
- smallRNAs 
- signal recognition particle 
- small temporal RNAs 
- tobacco acid pyrophosphatase 
- tris-acetate-EDTA 
- tris borate EDT A 
- transcription elongation factor-B 
- transfer-RNA 
- transfer-messenger RNAs 
- un-translated region 
- un-translated RNAs 
- volume per volume 
- weight per volume 
xiii 
RNOMIKS EKSPERIMENTAL: KEARAH PENGENALPASTIAN DAN 
PENCIRIAN ASID RIBONUKLEIK BUKAN-PENGKOD-PROTEIN DI DALAM 
AGEN PATOGENIK, SALMONELLA TYPHI 
ABSTRAK TESIS 
RNA bukan-pengkod-protein (npcRNA) merupakan satu kelas pengawalatur-ribo 
yang bertindak di dalam bentuk kompleks RNA-protein (sebagai RNPs) didalam 
pelbagai laluan pengawalaturan. Tesis ini memberikan tumpuan ke atas_ pengenalpastian 
npcRNA secara eksperimental daripada bakteria patogenik Salmonella enterica serovar 
Typhi (S. Typhi), penyebab penyakit demam kepialu. Melalui pendekatan RNomiks 
Eksperimental, 82 calon novel npcRNAdaripada perpustakaan cDNA S. Typhi telah 
dikenalpasti dan dicirikan. Daripada jumlah ini, 28 telah ditranskrip daripada IGR, 29 
ditranskrip di dalam arah antisense kepada ORF dan 18 dikenalpasti bertindihan dengan 
ORF. Sementara 7 calon yang lain telah ditranskIlp daripada kawasan repititif dan 
beberapa kedudukan bukan repitatif yang lain. Sebelas npcRNA merupakan npcRNAs 
yang telahpun dilaporkan. Menariknya, 55 daripada 82 calon yang dikenalpasti 
. mempamerkan homologi kepada Escherichia coli serta belum lagi dilaporkan dari kedua-
dua organisma. Melalui analisis Pemblotan Northern, pengungkapan 28 novel npcRNA 
.. telah berjaya disahkan. Sejumlah 38 cal on novel npcRNA adalah dikawalatur semasa fasa 
pertumbuhan, di mana 14 calon adalah dikawalatur semasa fasa pertumbuhan di dalam 
kedua-dua S. Typhi USM05 dan E. coli K12, 11 calon adalah dikawalatur semasa fasa 
pertumbuhan secara spesies-spesiftk hanya di dalam S. Typhi USM05 dan 3 calon adalah 
XIV 
dikawalatur semasa fasa pertumbuhan secara spesies-spesifIk hanya di dalam E. coli KI2. 
Sejumlah 8 calon npcRNA adalah diungkapkan secara ubikuitus, dimana 6 calon 
diungkapkan secara ubikuitus di dalam kedua-dua S. Typhi USM05 dan E. coli KI2. Dua 
calon adalah diungkapkan secara ubikuitus-spesies-spesifIk hanya di dalam S. Typhi 
USM05. Tidak ada calon yang diungkapkan secara ubikuitus-spesies-spesifIk di dalam E. 
coli KI2. Dua daripada 38 telah ditunjukkan dikawalatur semasa fasa pertumbuhan dan 
tumt diungkapkan secara ubikuitus. Ciri bagi corak pengungkapan berbeza yang telah 
diperhatikan boleh dihubungkaitkan dengan kelas npcRNA berbeza yang mana mereka 
dikumpulkan iaitu npcRNA untuk "housekeeping" dan untuk pengawa1aturan. Beberapa 
calon novel npcRNA telah ditunjukkan terletak berdekatan dengan gen-gen penting yang 
kekal di dalam E. coli KI2 dan di antara Salmonella. Justeru, adalah dicadangkan bahawa 
mereka mungkin adalah penting daripada segi fungsi. Secara signifIkan, kajian ini telah 
menetapkan suatu pemahaman ke atas kepentingan keadaan pertumbuhan yang spesifIk 
terhadap pengungkapan npcRNA. Dengan mempertimbangkan bahawa pengawalatur-
pengawalatur berkenaan mungkin diungkapkan apabila diaruhkan, molekul-molekul ini 
mungkin dapat diperkayakan dengan begitu banyak di dalam perpustakaan cDNA yang 
disediakan daripada keadaan pertumbuhan atau keadaan tekanan yang berkaitan. 
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EXPERIMENTAL RNOMICS: TOWARDS THE IDENTIFICATION AND 
CHARACTERIZATION OF NON-PROTEIN-CODING RIBONUCLEIC ACIDS 
IN PATHOGENIC AGENT, SALMONELLA TYPHI 
THESIS ABSTRACT 
Non-protein-coding RNA (npcRNA) is a large class of riboregulators that act in 
complex with proteins (as RNPs) in diverse regulatory pathways. This thesis focused on 
the experimental identification of small npcRNAs from Salmonella enterica serovar 
Typhi (s. Typhi), the aetiological agent of typhoid fever. By an Experimental RNomics 
approach, 82 species of uncharacterized novel npcRNA candidates were identified from 
library generated from different growth phases of a clinically isolated S. Typhi. From 
this, 28 were transcribed from the IGRs, 29 were transcribed in the antisense orientation 
of the ORFs and 18 were identified to overlap the ORFs. Another 7 candidates were 
transcribed from repetitive regions and several non-repetitive locations. Eleven known 
npcRNAs were also detected. Interestingly, 55 candidates exhibit homology to 
Escherichia coli and were not previously annotated for both organisms. By Northern Blot 
analysis, the expression of 38 novel npcRNA candidates was confinned. A total of 28 
novel npcRNA candidates were growth phase regulated where 14 candidates were growth 
phase regulated in both S. Typhi USM05 and E. coli K12, 11 candidates were species-
specific growth phase regulated only in S. Typhi USM05 and three candidates were 
species-specific growth phase regulated only in E. coli K12. A total of 8 npcRNA 
candidates were ubiquitously expressed with 6 candidates were ubiquitously expressed in 
xvi 
both S. Typhi USM05 and E. coli K12 and 2 candidates were species-specific 
ubiquitously expressed only in S. Typhi USM05. There was no species-specific 
ubiquitously expressed candidate observed in E. coli K 12. Two out of 3 8 candidates were 
shown to be growth phase regulated and ubiquitously expressed. The different feature of 
expression patterns observed in this study can be associated with the different classes of 
npcRNA that they might be grouped-in, namely the housekeeping and the regulatory 
npcRNAs. A number of novel npcRNA candidates were shown to be located close to 
important genes that were conserved in E. coli K12 and among Salmonella. Thus, 
suggesting that they might be functionally important. Significantly, thi_s study has set the 
understanding on the importance of the specific growth conditions to the expression of 
npcRNAs. The next phases of challenge are to further characterize and to elucidate the 
functions of these new classes of small RNA molecules. Considering that such regulators 
may be highly expressed upon induction, these molecules may be greatly enriched in 
cDNA libraries prepared from the relevant growth or stress condition. 
xvii 
(1.1) General Introduction 
CHAPTER 1 
INTRODUCTION 
It is believed that modem biochemistry arose with the first appearance of 
deoxyribonucleic acid (DNA), leading to the birth of "Central Dogma of Molecular 
Biology". The dogma defined a general pathway for the expression of genetic 
information stored in the DNA. The genetic information is transferred into messenger-
RNA (mRNA) through transcription by RNA polymerase and is then translated on 
ribosomes, a ribonucleoprotein complex of ribosomal-RNA (rRNA), with the help of 
specialized adapter, the transfer-RNA (tRNA), that carry specific amino acid, to produce 
functional proteins. These proteins, then· in tum perform all the enzymatic and structural 
functions in the cell. 
Consequently for decades, the belief that the critical functions of the cell and the 
complexity of an organism depend exclusively on the protein-coding genes according to 
"one gene, one protein" hypothesis (Morey and A vner, 2004) has progressively gained its 
ground and eventually created a great impact on genomic studies (e.g. genome 
sequencing project; Venter et al., 2001) in human and several selected model organisms, 
where the main interest have been put into discovering protein-coding genes (Eddy, 
2001; Morey and Avner, 2004). 
1 
The over-simplistic view may probably correct for the prokaryotic organisms 
where most of the earlier genetic studies have been done based on the "simple" and 
compact genome of the prokaryotes (pang et aI., 2006). However, with the discovery of 
the non-coding sequences or introns (Hastings and Krainer, 2001) that lies between 
protein-coding genes or exons, and intronic splicing activities of primary RNAs 
transcribed from eukaryotic genes, the dogma have been challenged. 
Furthermore, recent analysis of genomes strongly suggested that protein-coding 
genes alone are not enough to account for the complexity of higher organism (Mattick, 
2001). This can be seen from the evidences that with the increase of an organism 
complexity, the protein-coding genes contribution to its genome is tremendously 
decreased (Eddy, 2001; Szymanski and Barciszewski, 2002; Shabalina and Spiridonov, 
2004). The genomes of Caenorhabditis elegans and Drosophila melanogaster for 
example, were found to contain only twice as many protein-coding genes as in yeast and 
bacteria, and in human genome, the numbers is about twice that of the invertebrates 
(Mattick, 2001; Standish, 2002; Figure 1.1). 
The ribonucleic acid (RNA) molecule has been shown to be a versatile bio-
organic molecule with a variety of roles and functions in structural, genetic storage, 
regulatory and catalytic processes in living cell (Caprara and Nilsen, 2000). The 
identification of catalytic properties of the RNA subunit of ribonuclease P, aptamers, 
ribozymes, intronic self-splicing and gene silencing activities have further underlined the 
notion that the function of RNA molecules extended well beyond a transient role in 
2 
Homosapiens .11 •••••••••• , o Protein-coding sequence 
D. melanogaster ••••••••• 
I Non-proteiD-coding sequence 
A. tholiana •• iItI'-j--r...J 
c. elegans •••• IT-I 
S. serevisiae •••• ~r-T.....J 
M. tuberculosis ·Imi..__---.---r'--"'-T-"---'---..,r---' 
A·fulgidus 
Figure 1.1: The proportion of non-protein-coding and protein-coding sequences in several 
model organisms. The proportion of protein-coding sequences (light shaded bar) compared to 
protein-coding sequences (dark shaded bar) is increased in the genome of less complex organisms 
e.g., A. folgidus, M tuberculosis and E. coli. In contrast, the contribution of protein-coding 
sequences compared to the non-protein-coding sequences is decreased with the increase of the 
organism complexity as shown by fruit fly (D. melanogaster) and human (Homo sapien) where 
non-protein-coding sequences in human contributed approximately 98.5% to its genome (adapted 
from Szymanski and Barciszewski, 2002). 
3 
ensuring the expression of protein-coding genes (Levy and Ellington, 2001). It is 
estimated that 95% to 98.5% of the transcriptional output of eukaryotic genomes are un-
translated RNAs without protein-coding properties that are transcribed from non-coding 
sequences (Eddy, 2001; Mattick, 2001; Figure 1.1). 
In the literatures, the un-translated RNAs are generally referred as ~mall RNAs 
(sRNAs) or non-coding RNAs (ncRNAs). However, the term sRNAs is predominantly 
used for the un-translated RNAs in prokaryotes (Wassarman et aI., 1999; Suzuma et al., 
2002; Pichon and Felden, 2005). While the later, ncRNA is used for the un-translated 
RNAs found in eukaryotes and is originally used exclusively for polyadenylated 
eukaryotic RNAs transcribed by RNA polymerase II, carrying a 7 -methylguanosine cap 
structure but lacking open reading frame (ORP). Nowadays, the term ncRNA has been 
extended to designate any piece of RNA transcripts without protein-coding capacity in 
both prokaryotic andeukaryotic cells (Eddy, 2001; Mattick and Gagen, 2001; Morey and 
Avner, 2004; Liu et al., 2006; Pang et al., 2006). 
Less frequently used terms are un-translated RNAs (utRNAs), functional RNAs 
(fRNAs) and small non-coding RNAs (sncRNAs) (Ambros, 2001; Argaman et al., 2001; 
Erdmann et al., 2001b; Wagner and Flardh, 2002; Brosius, 2005; Vogel and Sharma, 
2005). Some authors have also referred them as non-messenger RNAs (nmRNAs) to 
discriminate them from mRNAs (HUttenhofer et al., 2001). Since the majority of the 
known ncRNAs are small in size, that ranged between 20-500 nucleotide (nt), 
HUttenhofer et al. (2001) coined and popularized the term small non-messenger RNAs 
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(snmRNAs) to refer to this group of ncRNAs. Recently, non-protein-coding RNAs 
(npcRNAs) tenn has also been used (Brosius and Tiedge, 2004) and the tenn npcRNAs is 
used in this thesis to refer to all the un-translated RNAs species. 
(1.2) Non-Protein-:Coding RNA (npeRNA) 
The npcRNA molecules have been shown to involve in variety of functions in all 
living cells. The npcRNAs in-complexed with proteins to form ribonucleoQrotein (RNP) 
complexes that functions in DNA and RNA stability. They also ~ction in diverse 
regulatory pathways including chromosome modification, transcriptional and 
translational control, splicing, development timing control, cell differentiation, 
proliferation, _ apoptosis, organ development, human diseases and immune system 
(Ambros, 2001; Szymanski and Barciszewski, 2002; Cheng et al., 2003; Ranum and Day, 
2004;; Mocellin et al;, 2006; O'Gonnan et al., 2006; Royo et a!., 2006; Barbarotto et al., 
2008; Kawaji and Hayashizaki, 2008). Their versatility has been known to be contributed 
by the chemical and physical properties of the RNA molecules (Johansson, 2005). 
The RNA molecules have been known to play important roles and functions well 
beyond the role of ensuring the expression of protein-coding genes (Caprara and Nilsen, 
2000; Levy and Ellington, 2001; Kawaji et al., 2008; Royo and Cavaille, 2008). Single-
stranded RNA molecules, for example, have been shown to posses the ability to fonn 
5 
pre-mRNA or mature RNA (Morey and Avner, 2004). Evolution of a small, specific 
complementary RNA can be achieved in a single step, just by a partial duplication of a 
fragment of the target gene into an appropriate context for expression of the new 
npcRNAs. 
Traditionally, many npcRNAs are grouped into specific classes based on their 
physical properties such as size, structure or sequence motives, protein partner or sub-
cellular location (Hiittenhofer et al., 2002). They might also be classified according to 
their functions such as catalyst, guides, catalytic cofactors, antisense RNAs, protein 
binding-site antagonists/agonist or templates (Hiittenhofer and Schattner, 2006). 
(1.3) Characteristic and Biogenesis of npcRNA 
Generally, npcRNAs often show only weak primary sequence conservation, lack 
of open reading frame (DRf') and are not systematically processed (Morey and A vner, 
... -
2004). Some npcRNAs such as the 16S and 23S rRNAs in bacteria are relatively large 
from 2,000 - 4,000 nt in length. However, majority of npcRNAs are usually very small 
with size between 20 - 500 nt. The npcRNA genes are expressed in only few cells or at 
specific cell growth stages/phases (Eddy, 2002; Yuan et al., 2003). 
Many are expressed at low level, that other may suggest that these RNAs are 
merely transcriptional noise from illegitimate promoters. Notably, in some large size 
npcRNAs, evolutionary conservation may not be a reliable signature of functional 
npcRNAs. Unlike DNA, npcRNAs that lack of conservation does not necessarily 
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indicates lack of function. A number of well-studied npcRNAs, for example human's 
XIST (17 kb) and mouse's Air npcRNAs are poorly conserved (Oudejans et al., 2001; 
Chureau et al., 2002) but are involved in dosage compensation and X-chromosome 
inactivation during development. 
In eukaryotes, npcRNAs are transcribed by different polymerases. For example, 
RNA polymerase I transcribed mostly ribosomal RNAs. RNA polymerase ill transcribed 
small structural RNAs like tRNAs and 5S-RNA. Whereas RNA polymerase II, 
transcribed mRNAs and most other npcRNAs. Long regulatory npcRNAs in Eukaryal are 
believed to be transcribed from within a well-defined gene with polymerase n promoters 
and sometimes are alternatively spliced and/or polyadenylated (Erdmann et aI., 2001a; 
Morey and Avner, 2004) and therefore might have evolved from genes that have lost 
their protein-coding capacity. Other long npcRNAs are thought to be of functional 
importance for cell viability and expressed from both chromosomes (Eddy, 2001). 
Some vertebrates' npcRNAs are transcribed as monocistronic units from 
independent genes (Maxwell and Fournier, 1995). However, many npcRNAs in plant and 
yeast are processed from polycistronic precursors (Maxwell and Fournier, 1995; 
Samarsky and Fournier, 1999). There are some of the eukaryotes' npcRNAs that are not 
independently transcribed at all but they are processed out of the introns of host 
transcripts (Eddy, 2002) or may be produced from intergenic transcription (Morey and 
A vner, 2004). Some host genes are non-protein coding and appeared to act exclusively as 
vehicles for npcRNAs only (Tycowski et al., 1996; Bortolin and Kiss, 1998; Pelczar and 
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Filipowicz, 1998). There are also npcRNAs that are generated from complex 
transcription unit of spanning tandem repetitions of the intron and non-protein coding 
flanking exons (Cavaille et al., 2000). The transcriptions of npcRNAs in eukaryotes are 
illustrated in Figure 1.2:A. 
Bacterial npcRNAs are mostly detected from the short intergenic region of the 
genomes and probably derived from unidirectional, convergent or divergent orientation 
of the ORFs (Rogozin et al., 2002). The transcriptions of npcRNAs in prokaryotes are 
illustrated in Figure 1.2:B. Most antisense npcRNAs appeared to overlap the 3' -ends un-
translated region (UTR) of the protein-encoding ORF, whereby the translation 
termination codon of the ORF falls in the 5' -end or 3' -end half of the npcRNA (Dahary et 
al., 2005). The base-pairing regulatory RNAs or riboregulators (antisense RNAs) usually 
found in bacteria exert their functions via blocking translation by sequestration of 
ribosome loading site, promote target RNA decay by creating RNase III substrates, 
induce premature termination of transcription, interf'ere with activator pseudoknots or 
even activate an mRNA by unfolding a ribosome-binding site (Wagner and Flardh, 
2002). Majority of antisense npcRNAs in bacteria are trans-encoded in the chromosome. 
The antisense RNAs can be separated into cis-encoded and trans-encoded groups. 
The cis-encoded group consisted of npcRNAs are encoded at the same genetic location 
but on the opposite strand to the RNA they act upon, thus exhibits a long perfect 
base-pairing with their potential target. The trans-encoded group on the other hand is 
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Figure 1.2: The organization of npcRNA genes. (A) npcRNA genes organization in 
eukaryote. In eukaryotes, npcRNAs can be transcribed either from (i) monocistronic units of 
independent protein-coding genes, (il) polycisfronic precursors of protein-coding genes cluster or 
intergenic region of the introns of host transcripts that are maybe (iii) single intronic region or (iv) 
long expanding intronic cluster. There are npcRNAs that are generated from (v) complex 
transcription unit of spanning tandem repetitions of the intron and protein-coding flanking exons. 
Some host genes are non-protein-coding genes and appeared to act exclusively as vehicles for 
npcRNAs only; they are similarly organized as in (i) and (ii), however the genes are non-protein-
coding genes. (B) npeRNA genes organization in prokaryote. In prokaryote, the npcRNAs can 
be derived from unidirectionaJ, convergent or divergent to the ORF's orientation (i.e, npcRNAl, 
npcRNA2, npcRNA3 and npcRNA4 are unidirectionally transcribed to GeneA, GeneB and 
GeneC, respectively; npcRNAS and npcRNA6 are convergently transcribed to GeneA and 
GeneB, respectively; npcRNAS and npcRNA6 are divergently transcribed to GeneB and GeneC, 
respectively). Bacterial npcNAs are mostly detected from the short intergenic spacer region of the 
genomes 'i.e, npcRNA2 and npcRNAS. The cis-antisense npcRNAs (i.e, npcRNAl) are 
transcribed from the opposite strand of the ORFs (i.e, GeneA). The trans-antisense npcRNAs (i.e, 
npcRNAl) may be transcribed from the same or opposite strand (i.e, npcRNA6) at a distance 
away from the ORFs (the red arrows indicated the target gene). Some npcRNAs can also be 
found to overlap the 3' end or 5' end of the ORFs where large sequences of the npcRNAs were in 
the intergenic region (i.e, npcRNA3, npcRNA4, npcRNA6 and npcRNA 7). NpcRNA: non-
protein-coding RNA (adapted from Huttenhofer et af., 2004). 
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consisted of npcRNAs that are encoded at a chromosomal location distinct from the RNA 
target they act upon and generally do not exhibit perfect base-pairing with their potential 
target (Figure 1.2:B) (Storz et al., 2005). 
Interestingly, there are significantly large numbers of bacterial trans-encoded 
antisense npcRNAs such as Mice, MicF and DsrA, that show strong requirement for the 
RNA chaperone protein complex; an Sm and Sm-like homolog regulator in the 
eukaryotes; known as host factor 1 (Hfq) (Moll et aI., 2003; Storz et aI., 2005; Vecerek et 
ai, 2008). Most of these npcRNAs share a similar structure composed of three stem-loops 
(Sauter et al., 2003; Zhang et al., 2003). The 11.2 kD Hfq protein forms a homo-
hexameric ring-shaped structure that bind to AU-rich sequences in npcRNAs (Wagner 
and Flardh, 2002; Moll et al., 2003; Storz et a!., 2005). Hfq binding can either promotes 
npcRNA-roRNA base-pairing, npcRNAlmRNA accessibility to RNases or protecting 
npcRNAlmRNA against Rnase-E via structural change in the npcRNA or mRNA 
(reviewed by Storz et al., 2005). The overview and model for the Hfq-mediated 
DsrAIRpoS regulation in E. coli is illustrated in Figure 1.3. 
(1.4) Known Function of npcRNAs 
Most npcRNAs are regulatory molecules that seemed to fine-tune cellular 
responses to environmental changes by integrating environmental signals into global 
regulation. They are involved in many important cellular processes such as post-
transcriptional gene silencing, RNA editing, pre-mRNA splicing, protein stability, 
nucleotide modification of RNA, mRNA stability and translation and growth phases or 
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Figure 1.3: Overview and model of Dsr AlHfqlrpoS-mediated regulation. In this model, The 
hexagonal ring, Hfq complex unfolds the rpoS 5' -leader at the RBS region, aIIowing DsrA 
Domain I to form base-pairing formation with the rpoS mRNA. This stabilizes an alternative 
conformer of rpoS mRNA that leads to increase translation of RpoS by exposing the RBS. SD: 
Sine-Delgamo sequence, RBS: ribosomal binding site, Hfq: host factor 1 protein, 5': 5' end, 3': 
3' end, Start: Start codon (adapted from Brescia et aI., 2003). 
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. developmental regulation (Eddy, 2001; Suzuma et al., 2002; Altuvia, 2004) through 
several mechanisms such as RNA-RNA or RNA-DNA base-pairing, RNA-protein 
interactions and intrinsic RNA activity (Altuvia and Wagner, 2000; Wassarman and 
Storz, 2000). The npcRNAs are also found to involve in other cellular processes such as 
DNA transcription, chromosome replication, RNA processing, protein synthesis and 
protein translocation. Some of the known functions of the npcRNAs in prokaryote and 
eukaryote are briefly described below. 
(1.4.1) npcRNA Functions in Post-Transcriptional Gene Silencing 
A class of small npcRNAs termed as micro RNAs (miRNAs) and short interfering 
RNAs (= small interfering RNAs; siRNAs) are found to involve in post-transcriptional 
gene silencing in eukaryotes. Both miRNAs and siRNAs are generated from long, 
double-stranded RNAs by a protein complex containing an RNase III-type endonuclease 
called Dicer (Grishok et al., 2001; Hutvagner et aI., 2001; Ketting et aI., 2001, Storz et 
al., 2005; Kawaji and Hayashizaki, 2008). 
Dicer cleaves double stranded RNA templates into short siRNAs of 21 to 23 nt 
that in turn, are able to target certain mRNA regions complementary to the siRNAs 
resulting in specific cleavage of the mRNA at this site and in loss of function of this 
mRNA (Bass, 2000; Zamore et al., 2000; Elbashir et al., 2001; Ketting et al., 2001; 
. . 
Nykanen et al., 2001; Zamore, 2001). This mechanism of mRNA degradation has been 
termed RNA interference (RNAi) (Fire et al., 1998) and is thOUght to have evolved as a 
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mechanism for antiviral defense by targeting certain double stranded RNA viruses 
(Hamilton and Baulcombe, 1999; Tabara et ai., 1999; Ketting et ai., 1999; Sharp and 
Zamore, 2000; Wu-Scharf et ai., 2000; Elbashir et ai., 2001; Waterhouse et ai., 2001). 
In miRNAs, the RNA precursors are stable stem-loop structures of 60 - 70 nt in 
length. The 22 nt miRNAs are processed from the stem portion of the precursor 
(Hutvagner et ai., 2001; Grishok et ai., 2001) and only one of the strands of the RNA 
helix is processed and stable. The lin-4 (22 nt) and let-7 (23 nt) are two examples of 
miRNAs found in C. eiegans. The common denominator between miRNAs and siRNAs 
is their size (21 - 23 nt) as well as a similar mechanism of generation i.e. from a larger 
RNA precursor. The generation and mechanism of action of siRNA and miRNA is 
illustrated in Figure 1.4. 
However, it is unclear whether the siRNA-endonuclease complex contains double 
stranded siRNA. The second difference between miRNAs and siRNAs is their function. 
While siRNAs are able to degrade specific mRNAs by the RNAi mechanism, miRNA 
presumably do not degrade their target mRNAs, but apparently exert their function at the 
level of translation regulation by binding to the 3' -UTRs of mRNAs. 
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Figure 1.4: Mechanisms of action for siRNA and miRNA. The 21-23 nt long siRNAs or 
miRNAs are processed from long, bimolecular or intramolecular RNA duplexes by Dicer and 
ATP; for miRNAs, only one strand appears to be stable while for siRNAs both strands can be 
detected at this stage; subsequently, miRNAs and siRNAs_l!Ssemble into RISCs (requiring ATP), 
that contain a single stranded RNA molecule and target mRNAs either in their ORFs or 3'-UTRs. 
For miRNAs this leads to translational arrest, while for siRNAs this results in cleavage of the 
mRNA target at the site of complementarity. As opposed to animal miRNAs, the majority of 
plant miRNAs have been proposed to function similar to siRNAs, namely degradation of 
mRNAs. ATP: adenosine triphosphate, miRNA: micro RNA, siRNA: short interference RNA, 
RISC: RNA-induced silencing complex, ORF: open reading frame, UTR: untranslated region 
(adapted from Rhoades et 01.,2002) 
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(1.4.2) npcRNA Functions in RNA Editing 
RNA editing is a co-transcriptional or post-transcriptional process by which a 
genome-encoded RNA sequence is altered by nucleotide insertions, deletions or base 
modifications (Figure 1.5). In the mitochondria of trypanosomatid protozoa, the 
precursors of messenger RNAs (pre-mRNAs) are edited by site-specific insertions and 
deletions of uridylate (V) residues. Small trans-acting, guide RNAs (gRNAs) supplied 
the genetic information for this RNA editing process. U-insertion editing occurs through 
a series of enzymatic steps that begins with gRNA-directed, pre-mRNA cleavage. 
Inserted U residues are derived from free uridine triphosphate and are added to the 3' 
terminus of as' pre-mRNA cleavage product (Kable et al., 1997; Simpson et al., 2000). 
(1.4.3) npcRNA Functions in Pre-mRNA Splicing 
In Eukarya, small nuclear RNAs (snRNAs) playa central role in the splicing of 
. pre-mRNAs (Will and Luhrmann, 2001). Eukaryal genes are often interrupted by introns 
. in primary transcripts. The mature RNAs are obtained_ after the introns are removed. In 
this process, several small nuclear RNAs (snRNA VI, U2, U4, V5 and U6) are involved . 
.. ' Together with their specific protein components, small nuclear ribonucleoprotein 
,(snRNP), they are required for the assembly of a ribonUcleoprotein complex termed the 
spliceosome. The spliceosome catalyzes splicing of pre-mRNAs by removing non-
.,...~ ... C&u"'" introns from eukaryal mRNA precursors (Moore and Sharp, 1993) (Figure 1.6). 
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Figure 1.5: Mechanism of U insertion/deletion RNA editing. The vertical lines indicate base 
pairs. The arrowheads indicate sites of cleavage. Modified enzyme cascade model. The 3' -oligo 
(U) tail of the gRNA (guide-RNA) is shown as a single-stranded overhang, but it is possible that 
the tail can interact with the purine-rich pre-edite~ sequence and the gRNA may have secondary 
structure. In the U deletion model 3 unpaired Us (in gray) to be deleted are shown as an example. 
It is possible that the U addition activity adds U's to the 3' -end of the cleavage fragment at the 
deletion site, which are then trimmed back, but this scenario is not indicated. In the U addition 
model 13 U's are shown added to the 5' -fragment, but the evidence indicates that the number of 
added Us is actually heterogeneous. In the 'guided' diagrams the exonuclease nucleotide 
trimming is complete, yielding the correct -3 or +3 guided products. If trimming is incomplete or 
excessive prior to ligation, gRNA-dependent misedited products are produced, as shown in the 
'misedited' diagram (adapted from Simpson and Emeson, 1996). 
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Figure 1.6: Spliceosome assembly. As the newly transcribed mRNA is emerging from the RNA 
polymerase II, Ul and U2 snRNPs bind through RNA:RNA base pairing to the 5' splice and 
branch sites, respectively. U2 snRNA binding is assisted by the U2AF, which interacts with the 
polypyrimidine tract and the 3' splice site. U5 snRNP enters as a part of the tri-snRNP complex 
with U4 and U6 snRNAs and base-pairs with the last two nucIeotides of exon 1 and the fIrst two 
nucleotides of exon 2. This brings together the two phosphodiester bonds that must be broken and 
reformed during splicing reaction. Acting like a chaperone, U4 initially base-pairs extensively 
with U6. This interaction is then disrupted so that U6 can interact with U2 near the activated 
adenosine branch point (bp). As U5 and U6 form these interactions with the pre-mRNA, Ul 
leaves, allowing U6 access to the 5' splice site. Through this trans-esterification reaction, the 
phoshodiester bond at the 5' splice site is broken, and eventually exon 1 is joined to exon 2, 
resulting in the mature mRNA product and the lariat intron (adapted from 
http://www.designeduniverse.comi<trticIes/Nobel_ Prize/spliceosome _ cycle.jpg, 2005). 
18 
(1.4.4) npcRNA Functions in Protein Stability 
Another unique bacterial npcRNA tenned transfer-messenger RNAs (tmRNAs) 
have been shown to affect protein stability. The ssrA RNA and 10Sa RNA are example of 
tmRNAs. They varied in size between 95 nt in S. Typhimurium LT2 to 466 nt in E. coli 
K12. The tmRNA is recognized as both tRNA and mRNA by stalled ribosomes (Gillet 
and Felden, 2001). When a ribosome is stalled, tmRNA is delivered to the site of the 
stalled ribosome and the nascent polypeptide is then transferred to the alanine-charged 
tRNA portion of tInRNA. The transcript is then placed by the mRNA portion of tmRNA, 
which encodes a tag for degradation of the stalled peptide. The mechanism and function 
oftmRNA is illustrated in Figure 1.7. 
(1.4.5) npcRNA Functions in Nucleotide Modification of RNA 
The biogenesis of eukaryal ribosomes in the nucleolus involves the processing of 
the rRNA primary transcript. Extended spacer regions from precursor rRNA are removed 
and mature ribosomal RNAs are generated. Before it$ cleavage by endonucleases and 
exonucleases, the nascent rRNA undergoes a pattern of nucleoside modifications. The 
two prevalent types of modification are 2'-O-ribose methylation or pseudouridylation. 
Each of these modifications is found at about 50 to 100 sites per eukaryal ribosome in 
..... contrast to the E. coli ribosome, which contains only four ribose-methylated nucleotides 
.. and 10 pseudouridines (Maden, 1990; Cavaille and Bachellerie, 1998). 
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Figure 1.7: Mechanism and function of tmRNA. A tmRNA is delivered to the site of a stalled 
ribosome and the nascent polypeptide (green boxes) is then transferred to the alanine-charged 
(yellow box) tRNA portion oftmRNA. The transcript is then placed by the mRNA portion of 
tmRNA, which encodes a tag (red boxes) for degradation-of the stalled peptide (adapted from 
http://www.indiana.eduJ-tmrnalimages/mode1.git). 
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Both types of modification are directed by small nucleolar ribonucleoprotein 
(snoRNPs), each composed a small nucleolar RNA (snoRNA) and a set of 
'-'-*,....f-<>1t11;1 (Maxwell and Fournier, 1995; Smith and Steitz, 1997; Weinstein and Steitz, 
999). The specificity of modification is achieved by base pairing of snoRNA with pre-
across the site to be modified. The snoRNAs are also involved in nucleotide 
lUUJLLl"""'~""" in spliceosomal snRNAs in vertebrates (Tycowski et a!., 1996; Hiitienhofer 
a!., 2001), tRNAs in Archaea and probably in eucaryotic mRNAs as well (Cavaille et 
,2000). 
The snoRNAs can be grouped into two major classes based on their structure and 
,conserved sequence motifs (Balakin et a!., 1996). The CID box family which guides 2'-
methylation and the HI ACA box family which guides pseudouridylation 
(Tollervey and Kiss, 1997; Smith and Steitz, 1997; Bachellerie et al., 2002) snoRNA 
;·rprlrpl;1pnt the most well studied npcRNAs. The structural feature of CID and HI ACA box 
'v~~.~~~ As is illustrated in Figure 1.8 and Figure 1.9. 
npcRNA Functions in mRNA Stability and Translation 
ill bacteria, npcRNAs can also be involved in regulation of translation by base-
upstream of the initiator AUG start codon where they either block translation or 
COllnpete with an inhibitory cis-acting secondary structure to open up the translation 
.llUI •• ,U .• Ull site (Wassarman et aI., 1999; Wagner et al., 2002). In E. coli, examples of these 
are OxyS RNA, DsrA RNA, and MicF RNAs. The mechanisms of action of 
npcRNAs are briefly illustrated in Figure 1.10. 
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Fig. 1.8: Structural features of elD box snoRNAs. (A) Schematic secondary structure of the 
eukaryotic CID box snoRNAs. Conserved motifs are boxed and sequence tracts complementary 
to the cognate RNA target (antisense elements) are depicited by thick blue lines. (B) Canonical 
structure of the CID guide RNA duplex. Indicated is the region of complementarity to target 
rRNA that is positioned S' to the D or' D' box; 2'·O-ribose methylation is directed to the 
nucleotide in the rRNA that participates in a Watson-Crick base pair five nucleotides upstream of 
the D' or D box. (C) Example of evolutionary conserved essential core proteins (adapted from 
Hiittenhofer et 01.,2004). 
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Fig. 1.9: Structural features of HlACA box snoRNAs. (A) Schematic secondary structure of 
, box HI ACA snoRNAs. Conserved motifs are boxed and sequence tracts 
fc()m1Jleltnelntary to the cognate RNA target (antisense elements) are depicited by thick blue lines. 
{B) Canonical structure of the HlACA guide RNA duplex. Indicated is the region containing one 
or two sequence tracts complementary to rRNA that are located within the bulge region of the 5' 
or 3' helices; base pairing to rRNA positions the uridine nucleotide to be modified in the 
pocket between the regions of rRNA-snoRNA complementarity. The target 
is located 14 to 16 nt upstream from the ACA or H box. N: any nucleotide. (C) Example 
evolutionary conserved essential core proteins (adapted from Hiittenhofer et al., 2004). 
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1.10: Mechanism. of translational inhibition/activation in E. coli directed by npcRNAs. 
npcRNA binds to Shine-Dalgamo sequence and/or initiation codon, thereby inhibiting 
, ..... ~ ......... ' ... of the ORF. (B) npcRNA disrupts the double-strand RNA structures between 5'-UTR 
SD thus allowing translation to occur. SD: Shine-Dalgamo sequence, ATG: initiation codon, 
Open reading frame, 5'-UTR: 5'-untranslated region, 3'-UTR: 3'-untranslated region 
la(lllPte~a from Tang et 01.,2002). 
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